Ilana Fogelman

Ilana Fogelman is the founder of C2N Diagnostics LLC, founded in 2007, and LifeTech Research, Inc., founded in 2003.
At LifeTech Research, Inc., she holds the title of Chief Operating Officer starting in 2003.
Currently, Ms. Fogelman is the Chief Executive Officer at miCure Therapeutics Ltd since 2022 and also serves as a Director at Rare-X.
In the past, she worked as an Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. in 2002.
From 2008 to 2015, she was the Managing Partner at LifeTech Development Partners LP.
Ms. Fogelman also held a position as a Principal at Salomon Smith Barney.
She completed her graduate degree at Harvard University in 1993 and earned a doctorate degree from the University of Sao Paulo.